Afasevikumab (RG 7624, RO 5553110, NI-1401) is a fully human monoclonal IgG1kappa antibody neutralizing both IL-17A and IL-17F. Afasevikumab has anti-inflammatory activities[1].
Molecular Weight:
(146.065 kDa)
Purity:
95
CAS Number:
[1589503-30-9]
Target:
Interleukin Related
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted